Telara Pharma is a global leader in repurposing the drug cilastatin to make new therapies for severe inflammatory disorders like Acute Kidney Injury (AKI) and Glaucoma.
The scientific team of TELARA has spent years studying toxic and non-toxic aggressions suffered by the kidneys with the aim of preventing and treating AKI. The company arises out of the pioneering work on nephroprotection carried out with cilastatin by the team of the KOL Dr. Alberto Tejedor.
We are currently advancing cilastatin into phase II clinical trials for the treatment of AKI induced by toxics, sepsis, and sepsis-included acute kidney failure and moving forward proprietary programs to clinical trials to repurpose cilastatin for neuroinflammatory disorders like Glaucoma and other ophthalmologic indications.
Company Details
- Employees
- 6
- Founded
- -
- Address
- Calle De Baldiri Reixac, 4, Parc Científic De Barcelona,spain
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://telarapharma.com/
- Keywords
- Barcelona.
- HQ
- Barcelona, Catalonia
Telara Pharma Questions
Telara Pharma's website is https://telarapharma.com/
Telara Pharma's LinkedIn profile is https://es.linkedin.com/company/telarapharma
Telara Pharma has
6 employees.
View email and phone details for 6
employees at Telara Pharma.
Telara Pharma's industry is
Biotechnology Research
Telara Pharma's top competitors are
Miwendo Solutions,
Flomics,
Robopedics,
Ahead Therapeutics,
Beyond You (Formerly Exheus),
Mowoot,
Accure Therapeutics,
Arch Biopartners Inc (Arch:tsxv) (Achff:otcqb),
Ephion Health,
Anaconda Biomed.
Telara Pharma's categories are Biotechnology Research
Telara Pharma's founding year is 2020
